X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Sarah Sutton

Sarah Sutton Sarah is a senior manager of public affairs at PhRMA focusing on communications strategies and activities for the organization’s state advocacy priorities. Prior to joining PhRMA, Sarah worked in public affairs at the U.S. Department of Justice. Outside of the office, Sarah can be found running, trying new recipes and cheering on the N.C. State Wolfpack.

Recent Posts

Prescription drug prices are not fueling inflation

By Sarah Sutton  |    July 6, 2022
Inflation is causing pain for people across the country. As policymakers search for ways to help provide relief, some are erroneously tying inflation to prescription medicines. To make matters worse,...   Read More

What they are saying: Government price setting for medicines is not the answer

By Sarah Sutton  |    November 4, 2021
America’s biopharmaceutical companies continue to voice the dangers of current proposals in Washington that would allow the government to set prices for medicines. While it’s being called government...   Read More

PhRMA’s Lori Reilly joined CSG to discuss the industry’s response to COVID-19 and what it means for states

By Sarah Sutton  |    July 13, 2020
Recently, Lori Reilly, Chief Operating Officer at PhRMA, participated in a podcast with the Council of State Governments (CSG) to discuss the important work the biopharmaceutical industry is doing to...   Read More

New report: Biopharmaceutical industry supports over 4 million jobs and $1.1 trillion in U.S. economic output

By Sarah Sutton  |    February 12, 2020
Across the country, the biopharmaceutical sector supports millions of jobs in its pursuit to discover ground-breaking treatments and cures for patients around the world.   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."